Potassium Carbonate → 5-((S)-2,2-dimethyl-[1,3]dioxolan-4-yl)-pyrazin-2-ylamine

HRID 12002

反応式

HRID 12002 の反応式
[CH3:1][C:2]1([CH3:20])[O:6][C@@H:5]([C:7]2[N:8]=[CH:9][C:10]([NH:13]C(=O)C(C)(C)C)=[N:11][CH:12]=2)[CH2:4][O:3]1.C(=O)([O-])[O-].[K+].[K+]>CO>[CH3:1][C:2]1([CH3:20])[O:6][C@@H:5]([C:7]2[N:8]=[CH:9][C:10]([NH2:13])=[N:11][CH:12]=2)[CH2:4][O:3]1

参加物

4

反応条件

温度
25 °C

実験手順

A mixture of N-[5-((S)-2,2-dimethyl-[1,3]dioxolan-4-yl)-pyrazin-2-yl]-2,2-dimethyl-propionamide (8.4 g, 30.7 mmol) and potassium carbonate (4.32 g, 31.2 mmol) in methanol (150 mL) was stirred at 25° C. for 16.5 h, at which time, thin layer chromatography suggested partial conversion to a more polar product. In an effort to avoid epimerization at the stereogenic center, the reaction was discontinued before completion. Therefore, the solvent was removed under reduced pressure at 25° C. The resulting residue was again concentrated in vacuo from ethyl acetate (50 mL). The material was purified using Biotage chromatography (FLASH 40 L, Silica, ethyl acetate). The early fractions collected allowed for the recovery of unreacted starting pivaloylamide as a white solid (2.0 g, 24%). The later fractions were concentrated in vacuo to provide 5-((S)-2,2-dimethyl-[1,3]dioxolan-4-yl)-pyrazin-2-ylamine (3.7 g, 63%) as a pale yellow oil. High-performance liquid chromatography analysis with a chiral column indicated 100% ee.

後処理

  1. customTherefore, the solvent was removed under reduced pressure at 25° C
  2. concentrationThe resulting residue was again concentrated in vacuo from ethyl acetate (50 mL)
  3. customThe material was purified
  4. customThe early fractions collected
  5. concentrationThe later fractions were concentrated in vacuo

出典と根拠

ORDレコード
ord-9d5a4d4f98314113864f6374baf40375
出典データセット
uspto-grants-2010_06
特許番号
US07727750B2

関連ノート

読み込み中…